754 related articles for article (PubMed ID: 14769817)
1. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
2. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
Tubaro C; Arcuri C; Giambanco I; Donato R
J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
[TBL] [Abstract][Full Text] [Related]
3. Transduction of MyoD protein into myoblasts induces myogenic differentiation without addition of protein transduction domain.
Noda T; Fujino T; Mie M; Kobatake E
Biochem Biophys Res Commun; 2009 May; 382(2):473-7. PubMed ID: 19289111
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner.
Schabort EJ; van der Merwe M; Loos B; Moore FP; Niesler CU
Exp Cell Res; 2009 Feb; 315(3):373-84. PubMed ID: 19038250
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
Ono Y; Sakamoto K
PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
[TBL] [Abstract][Full Text] [Related]
6. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.
Melcon G; Kozlov S; Cutler DA; Sullivan T; Hernandez L; Zhao P; Mitchell S; Nader G; Bakay M; Rottman JN; Hoffman EP; Stewart CL
Hum Mol Genet; 2006 Feb; 15(4):637-51. PubMed ID: 16403804
[TBL] [Abstract][Full Text] [Related]
7. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis.
Dahlman JM; Wang J; Bakkar N; Guttridge DC
J Cell Biochem; 2009 Jan; 106(1):42-51. PubMed ID: 19016262
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
[TBL] [Abstract][Full Text] [Related]
9. Bakuchiol augments MyoD activation leading to enhanced myoblast differentiation.
Lee SJ; Yoo M; Go GY; Kim DH; Choi H; Leem YE; Kim YK; Seo DW; Ryu JH; Kang JS; Bae GU
Chem Biol Interact; 2016 Mar; 248():60-7. PubMed ID: 26902638
[TBL] [Abstract][Full Text] [Related]
10. FHL3 binds MyoD and negatively regulates myotube formation.
Cottle DL; McGrath MJ; Cowling BS; Coghill ID; Brown S; Mitchell CA
J Cell Sci; 2007 Apr; 120(Pt 8):1423-35. PubMed ID: 17389685
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
Horwitz M
Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome-mediated degradation and synthesis of MyoD is modulated by alphaB-crystallin, a small heat shock protein, during muscle differentiation.
Singh BN; Rao KS; Rao ChM
Biochim Biophys Acta; 2010 Feb; 1803(2):288-99. PubMed ID: 20005263
[TBL] [Abstract][Full Text] [Related]
13. ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-κB signaling activity.
Liu XH; Bauman WA; Cardozo C
Biochem Biophys Res Commun; 2015 Aug; 464(1):208-13. PubMed ID: 26102030
[TBL] [Abstract][Full Text] [Related]
14. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
Ardite E; Barbera JA; Roca J; Fernández-Checa JC
Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
17. c-Myb inhibits myogenic differentiation through repression of MyoD.
Kaspar P; Pajer P; Sedlak D; Tamaoki T; Dvorak M
Exp Cell Res; 2005 Oct; 309(2):419-28. PubMed ID: 16055116
[TBL] [Abstract][Full Text] [Related]
18. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
19. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
20. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
Ishibashi J; Perry RL; Asakura A; Rudnicki MA
J Cell Biol; 2005 Nov; 171(3):471-82. PubMed ID: 16275751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
